Resolys Bio's Unattributed Round

Resolys Bio raised a round of funding on September 25, 2017.

Resolys Bio is a privately held, discovery and early-stage development biotechnology company of therapeutic agents for acute and chronic disorders. BTL has several products in pre-clinical and clinica…

Articles about Resolys Bio's Unattributed Round: